Marex director granted 2,070 restricted shares

Pickering Robert Mark reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Pickering Robert Mark reported acquisition or exercise transactions in this Form 4 filing.

Marex Group plc director Robert Mark Pickering received an equity grant of 2,070 ordinary shares in the form of restricted share awards. The grant was made at no cash cost per share and increases his direct holdings to 31,766 ordinary shares, including the unvested awards that will deliver one share per award upon vesting.

Insights

Equity compensation analyst

Director received a routine stock-based compensation grant.

The filing shows Robert Mark Pickering, a director of Marex Group plc, acquiring 2,070 ordinary shares through restricted share awards. The awards were granted at a price of $0.00 per share, indicating compensation rather than an open-market purchase.

These restricted share awards represent a contingent right to receive one ordinary share per award upon vesting and settlement. After the grant, Pickering holds 31,766 ordinary shares directly, so this appears to be a modest, ongoing component of his board compensation rather than a directional market bet.

Insider Trade Summary

Grant/Award: 2,070 shares

Grant/Award 1 txn

Insider Pickering Robert Mark

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares	2,070	$0.00	$0.00

Holdings After Transaction: Ordinary Shares — 31,766 shares (Direct)

Footnotes (1)

1. F1. The number of ordinary shares reported herein includes 2,070 shares underlying restricted share awards granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.

Key Figures

Restricted share awards granted: 2,070 shares Grant price per share: $0.00 per share Shares held after transaction: 31,766 shares

3 metrics

Restricted share awards granted 2,070 shares Ordinary Shares grant on June 9, 2026

Grant price per share $0.00 per share Restricted share awards to director

Shares held after transaction 31,766 shares Director’s direct holdings following grant

Key Terms

restricted share awards, contingent right, vesting and settlement

3 terms

restricted share awards financial

"includes 2,070 shares underlying restricted share awards granted to the Reporting Person"

Restricted share awards are grants of company stock given to employees or executives that cannot be sold or transferred until certain conditions—typically staying with the company for a set time or meeting performance goals—are met. They matter to investors because they can dilute existing shares when they vest, signal management’s incentives and confidence, and affect a company’s future earnings per share much like a delayed paycheck that becomes available only after you meet agreed milestones.

contingent right financial

"Each award represents a contingent right to receive one (1) ordinary share"

vesting and settlement financial

"upon vesting and settlement of the applicable award"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Marex Group plc (MRX) director Robert Mark Pickering report on this Form 4?

Robert Mark Pickering reported receiving 2,070 Marex Group plc ordinary shares as restricted share awards. These equity awards are compensation, not open-market purchases, and increase his direct holdings to 31,766 ordinary shares following the transaction on June 9, 2026.

How many Marex Group plc (MRX) shares did the director acquire, and at what price?

The director acquired 2,070 ordinary shares of Marex Group plc through restricted share awards at a grant price of $0.00 per share. This indicates a stock-based compensation grant rather than a cash-funded market purchase of shares.

What are the restricted share awards reported by Marex Group plc (MRX) director?

The filing states the 2,070 awards are restricted share awards, each representing a contingent right to receive one ordinary share. The shares are delivered only upon vesting and settlement of the applicable award, so they function as time-based equity compensation.

What is Robert Mark Pickering’s Marex Group plc (MRX) shareholding after this grant?

After the reported grant, Robert Mark Pickering directly holds 31,766 Marex Group plc ordinary shares. This total includes the 2,070 shares underlying the restricted share awards, which will be issued upon vesting and settlement of those awards, according to the filing footnote.

Does this Marex Group plc (MRX) Form 4 involve any share sales by the director?

No share sales are reported in this Form 4. The filing shows only an acquisition transaction coded as a grant or award, with 2,070 restricted share awards added to the director’s holdings and no dispositions, exercises, or open-market sales disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/11/2026 - 04:05 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pickering Robert Mark

(Last) (First) (Middle)

C/O MAREX GROUP PLC, 155 BISHOPSGATE

(Street)

LONDON UNITED KINGDOM EC2M 3TQ

(City) (State) (Zip)

UNITED KINGDOM

(Country)

2. Issuer Name and Ticker or Trading Symbol
Marex Group plc [ MRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	06/09/2026		A		2,070	A	$0	31,766(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The number of ordinary shares reported herein includes 2,070 shares underlying restricted share awards granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.

	/s/ Scott Linsley as Attorney-in-Fact, for Robert Mark Pickering	06/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)